echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > 40 large varieties start to purchase with quantity (list attached)

    40 large varieties start to purchase with quantity (list attached)

    • Last Update: 2020-06-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit
    < br / >It is reported that the centralized procurement of 40 varieties in Shandong Province will start in July, and the specific bidding results may be implemented in September< br / > on April 23, Shandong Medical Insurance Bureau issued the notice on organizing and filling in part of drug purchase plans, announcing the start of volume purchase in Shandong ProvinceAccording to the notice, 40 varieties were selected mainly according to the principle of large clinical dosage, high purchase amount and full competition< br / > according to cypress blue, aspirin, nifedipine, metoprolol, flunarizine, omeprazole, rabeprazole, compound glycyrrhizin, lansoprazole and L-amlodipine are all in the range of collection in Shandong ProvinceIt is worth noting that there are 27 injection types and 13 oral dosage forms in 40 varieties, accounting for more than two-thirds of injection types< br / > in the notice, Shandong called on the provincial public medical institutions (including general hospitals, traditional Chinese medicine hospitals, specialized hospitals, maternity and child care centers, sanatoriums, social health service institutions, township hospitals, etc.) and military medical institutions in Shandong to fill in the procurement plan, and encouraged the medical Insurance Association to manage private medical institutions to participate voluntarily< br / > Shandong Province requires medical institutions to fill in the purchase demand quantity of related drugs in one year (12 months after the official implementation) with reference to the actual use quantity in 2019, and requires medical institutions to complete online filling within three daysIt is not hard to see that the procurement cycle of local centralized mining in Shandong Province is still one year< br / > according to relevant people, nifedipine controlled-release tablets (Bayer, Shanghai Hyundai) and tacrolimus (anstelai, China, the United States and East China) have independent bargaining rights among the 40 products purchased in volume< br / > up to now, according to cypress blue, except for Shandong, Hunan, Hebei, Anhui, Fujian, Jiangxi, Shanxi, Yunnan and Qinghai provinces have started their own provincial-level centralized procurement, mainly targeting high blood pressure and diabetes drugs, high-cost antibacterial drugs, anti-tumor drugs, basic infusion and other varieties< br / > it has been revealed that the general rules of this centralized purchase in Shandong Province are as follows: < br / > the first level is the original research drug, expired patent drug, over consistency evaluation drug, generic reference drug catalog, Chinese drug listing catalog, and drugs exported to Britain, France, Germany, Canada, the United States, Australia and Japan< br / > drugs in other cases are divided into the second levelIn the second level, 0.5 points will be added for each item with the second prize of scientific and technological progress and the indication of product increase< br / > for the same generic drug, each quality level can only win two bids at most< br / > comprehensively consider the price reduction range, market share and coverage index< br / > if there are three or more companies at one level bidding, it shall be calculated according to the comprehensive score, in which the price accounts for 60%, the sales volume 20%, and the coverage 20%Including basic community hospitalsThe highest score is the first order winning variety, and the second highest score must accept this priceIf the price cannot be reduced to this level, it shall be deemed as abandonment, that is, the bid will be dropped< br / > the occupancy and coverage of two bids at one level shall be calculated first, and the highest score shall be discussed firstAcceptance of two conditions can win the bid, one is based on the average reduction of three or more bids for other varieties at the same level, the other is not higher than the existing network price of another product platform, and if the reduction is not reached, it will be deemed as abandonment< br / > A bidder must accept one of two conditions, or accept the average decline of more than three products at the same level, or accept the average decline of all products< br / > if there are two products winning the bid in one level, the two products will jointly divide 70% of the total reported volume of medical institutions in the provinceIf there is only one winning bidder, 60% of the total reported volume of medical institutions in the province shall be dividedIf there is no winning product in one level, 50% of the reported quantity in that level will be given to the same generic product in another level< br / > in terms of regional selection, the first winning bidder selects one city first, and then alternates in turn, which is similar to the setting of provincial selection rules for centralized purchase in China< br / > in general, no matter in Shandong province or other provinces carrying out local centralized purchase, there are varieties and rule breakthroughs to varying degrees under the principle of volume purchase, such as a large number of varieties that have not been evaluated for consistency, many injection types, and quality levels< br / > some of these breakthroughs have distinctive local characteristics, some may become important attempts and ultimately provide experience for a new round of national centralized miningIn a word, no matter which one, it is worth high attention of pharmaceutical enterprises
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.